Abstract:Herein a successful strategy for cancer treatment by nanomedicine‐potentiated NK cell immunotherapy is presented. BPQDs@HSA activates PI3K‐Akt‐mTOR signaling pathways to reprogram cell metabolism of glycolysis and further promote the oxidative phosphorylation, sequentially maintains the cell viability and immunity of NK cells. BPQDs@HSA can also enhance immune tumoricidal and immune surveillance, relieve immune suppression, and inhibit tumor immune escape. Low persistence, metabolic dysfunction in microenvironment, and tumor‐derived immunosuppression of Natural killer (NK) cells in patients are greatly limited the successful clinical application of NK cell‐based cancer immunotherapy. Interestingly, herein that human serum albumin‐encapsulated black phosphorus quantum dots (BPQDs@HSA) can effectively augment antitumor efficacy of clinical patients‐derived NK cell immunotherapy is found. As the donor of phosphate group, BPQDs@HSA binds with the protein of phosphatidylinositol 4‐phosphate 5‐kinase type‐1 gamma (PIP5K1A) and activates the downstream PI3K‐Akt and mTOR signaling pathways to reprogram cell metabolism of glycolysis and further promote the oxidative phosphorylation, sequentially maintains the cell viability and immunity of NK cells. And multiomics analysis is therefore conducted to reveal the underlying immunoregulation mechanisms, and that BPQDs@HSA can interact with the Toll‐like receptor (TLR) on the NK cell surface and increase the expression level of mTOR, and thus activate downstream NF‐κB signalling pathways to regulate cytokine secretion and enhance immune tumoricidal is found. BPQDs@HSA can also enhance immune surveillance, relieve immune suppression, and inhibit tumor immune escape. Collectively, this study not only demonstrates a successful strategy for nanomedicine‐potentiated immune‐cancer therapy, but also sheds light on the understanding of interface between nanomedicine and immune cells activation.

Cancer Cell-Specific Autophagy Activation Using Phosphorus-Based Nanoplatform As Anabolism Activator

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Augmenting Tumor‐Starvation Therapy by Cancer Cell Autophagy Inhibition

Engineering Nanoplatform for Combined Cancer Therapeutics via Complementary Autophagy Inhibition

Fluorescent hyaluronic acid nanoprodrug: A tumor-activated autophagy inhibitor for synergistic cancer therapy

Click-Nucleic-Acid-Containing Codelivery System Inducing Collapse of Cellular Homeostasis for Tumor Therapy Through Bidirectional Regulation of Autophagy and Glycolysis.

Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy

Homologous Targeting Cascade Nanobioreactor for Autophagy Inhibition Amplified Tumor Catalytic Therapy

A phosphatase-like nanomaterial promotes autophagy and reprograms macrophages for cancer immunotherapy

3-Bromopyruvate-conjugated Nanoplatform-Induced Pro-Death Autophagy for Enhanced Photodynamic Therapy Against Hypoxic Tumor

Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy.

Nanomedicine for cancer targeted therapy with autophagy regulation

Nanotherapeutics targeting autophagy regulation for improved cancer therapy

Harnessing endocytic pH gradients for cascaded formation of intracellular condensates to inhibit autophagy: A pathway to cancer therapy

Site-Specific Location of Black Phosphorus Quantum Dot Cluster-Based Nanocomplexes for Synergistic Ion Channel Therapy and Hypoxic Microenvironment Activated Chemotherapy

Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells

Black phosphorus quantum dots as multifunctional nanozymes for tumor photothermal/catalytic synergistic therapy

Cancer Cells Escape Autophagy Inhibition Via NRF2-induced Macropinocytosis.

Black Phosphorus, an Emerging Versatile Nanoplatform for Cancer Immunotherapy

Autophagy, Metabolism, and Cancer

Photo-activated autophagy-associated tumour cell death by lysosome impairment based on manganese-doped graphene quantum dots